Index by author
September 01, 2013; Volume 41,Issue 9
Dickmann, Leslie J.
- You have accessCritical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White PaperRaymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei ZhangDrug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
Dufek, Matthew B.
- You have accessIntestinal First-Pass Metabolism by Cytochrome P450 and Not P-Glycoprotein Is the Major Barrier to Amprenavir AbsorptionMatthew B. Dufek, Arlene S. Bridges and Dhiren R. ThakkerDrug Metabolism and Disposition September 2013, 41 (9) 1695-1702; DOI: https://doi.org/10.1124/dmd.113.052191
Ekstrom, Lena
- You have accessAtorvastatin Treatment Induces Uptake and Efflux Transporters in Human LiverLinda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena EkströmDrug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
Eriksson, Mats
- You have accessAtorvastatin Treatment Induces Uptake and Efflux Transporters in Human LiverLinda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena EkströmDrug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
Evers, Raymond
- You have accessCritical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White PaperRaymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei ZhangDrug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
Fahmi, Odette A.
- You have accessCritical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White PaperRaymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei ZhangDrug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
Finel, Moshe
- You have accessThe Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid GlucuronidationMartin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier BarbierDrug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
Flockhart, David A.
- You have accessInhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of NorendoxifenJinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. FlockhartDrug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
Flockhart, Peter J.
- You have accessInhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of NorendoxifenJinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. FlockhartDrug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
Gauthier-landry, Louis
- You have accessThe Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid GlucuronidationMartin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier BarbierDrug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
In this issue
Advertisement